Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kislay Roy

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Nanomedicine|February 14, 2015
Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer modelKislay Roy, Rupinder K Kanwar, Subramanian Krishnakumar, et al.
International Journal of Nanomedicine|April 22, 2016
Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancersSishir K Kamalapuram, Rupinder K Kanwar, Kislay Roy, et al.
International Journal of Nanomedicine|January 6, 2016
Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cellsKislay Roy, Yogesh S Patel, Rupinder K Kanwar, et al.
Frontiers in Pharmacology|January 8, 2019
Corrigendum: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal HazeKislay Roy, Prasad Neerati, Chun Hei Antonio Cheung, et al.
Frontiers in Pharmacology|May 23, 2017
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal HazeKislay Roy, Prasad Neerati, Chun Hei Antonio Cheung, et al.
Cancers|January 13, 2018
EpCAM Immunotherapy versus Specific Targeted Delivery of DrugsJoanna Macdonald, Justin Henri, Kislay Roy, et al.
Current Medicinal Chemistry|February 28, 2015
Nucleic acid-based aptamers: applications, development and clinical trialsJagat R Kanwar, Kislay Roy, Nihal G Maremanda, et al.
Nanomedicine (London, England)|July 15, 2014
Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zincJagat R Kanwar, Ganesh Mahidhara, Kislay Roy, et al.
Biomicrofluidics|October 22, 2015
Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cellsNihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
Biomicrofluidics|September 5, 2017
Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)]Nihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Nanomedicine|February 14, 2015
Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer modelKislay Roy, Rupinder K Kanwar, Subramanian Krishnakumar, et al.
International Journal of Nanomedicine|April 22, 2016
Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancersSishir K Kamalapuram, Rupinder K Kanwar, Kislay Roy, et al.
International Journal of Nanomedicine|January 6, 2016
Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cellsKislay Roy, Yogesh S Patel, Rupinder K Kanwar, et al.
Frontiers in Pharmacology|January 8, 2019
Corrigendum: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal HazeKislay Roy, Prasad Neerati, Chun Hei Antonio Cheung, et al.
Frontiers in Pharmacology|May 23, 2017
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal HazeKislay Roy, Prasad Neerati, Chun Hei Antonio Cheung, et al.
Cancers|January 13, 2018
EpCAM Immunotherapy versus Specific Targeted Delivery of DrugsJoanna Macdonald, Justin Henri, Kislay Roy, et al.
Current Medicinal Chemistry|February 28, 2015
Nucleic acid-based aptamers: applications, development and clinical trialsJagat R Kanwar, Kislay Roy, Nihal G Maremanda, et al.
Nanomedicine (London, England)|July 15, 2014
Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zincJagat R Kanwar, Ganesh Mahidhara, Kislay Roy, et al.
Biomicrofluidics|October 22, 2015
Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cellsNihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
Biomicrofluidics|September 5, 2017
Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)]Nihal G Maremanda, Kislay Roy, Rupinder K Kanwar, et al.
Pageof 3